Singapore markets open in 7 hours 35 minutes
Straits Times Index
3,074.26 -12.98 (-0.42%) S&P 500
4,583.26 +33.92 (+0.75%) Dow
36,081.98 +27.55 (+0.08%) Nasdaq
14,340.18 +193.47 (+1.37%) Bitcoin USD
43,672.40 -393.71 (-0.89%) CMC Crypto 200
899.35 +6.63 (+0.74%)
AZN Jan 2025 70.000 put
OPR - OPR Delayed Price. Currency in USD
Add to watchlist
As of 10:32AM EST. Market open.
| Previous close | 8.30 |
| Open | 8.40 |
| Bid | 8.75 |
| Ask | 8.90 |
| Strike | 70.00 |
| Expiry date | 2025-01-17 |
| Day's range | 8.30 - 8.40 |
| Contract range | N/A |
| Volume | |
| Open interest | 2.19k |
- PR Newswire
Koselugo now available in Malaysia for paediatric patients with symptomatic neurofibromatosis type 1 (NF1) plexiform neurofibromas
AstraZeneca's Koselugo (selumetinib) is now available in Malaysia as a monotherapy for the treatment of paediatric patients three years of age and older with neurofibromatosis type 1 (NF1) who have symptomatic, inoperable plexiform neurofibromas (PN)1. Koselugo, which received regulatory approval earlier this year, is a product approved by the National Pharmaceutical Regulatory Agency (NPRA) for NF1 with inoperable PN.
ZacksAstraZeneca PLC (AZN) Is a Trending Stock: Facts to Know Before Betting on It
Zacks.com users have recently been watching Astrazeneca (AZN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
ZacksAbsci (ABSI) Up on AstraZeneca Deal to Design New Cancer Therapy
Absci (ABSI) announces a collaboration agreement with AstraZeneca to develop an AI-designed antibody for an undisclosed oncology target. The stock rises 13%.
© 2023 Yahoo. All rights reserved.